BofA/Merrill Lynch Downgrades Karyopharm Therapeutics (KPTI) to Underperform
Go back to BofA/Merrill Lynch Downgrades Karyopharm Therapeutics (KPTI) to UnderperformKARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 1.07 -0.02 (1.83%) | |||||
---|---|---|---|---|---|---|
Previous Close | $1.09 | 52 Week High | $19.41 | |||
Open | $1.07 | 52 Week Low | $4.83 | |||
Day High | $1.10 | P/E | N/A | |||
Day Low | $1.03 | EPS | $-2.74 | |||
Volume | 392,966 |